🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to investigate the safety profile of AZD4721 after single doses at di...
Status
Completed
Location
Research Site
Start Date
2013-07
Trial ID
NCT01889160
Treatments Being Tested
The goal of treatment with AICS is weaning from oral corticosteroids, i.e. ...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01200108
Treatments Being Tested
The primary purpose of this study is to evaluate the safety profile and tol...
Status
Completed
Location
West Coast Clinical Trials, Llc
Start Date
2008-01
Trial ID
NCT00559247
Treatments Being Tested
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Controlled, Sequ...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-06
Trial ID
NCT02485769
Treatments Being Tested
To compare the effect on glycemic control (HbA1c) of exenatide suspension a...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01652729
Treatments Being Tested
The purpose of this study is to investigate the effect on the frequency of ...
Status
Withdrawn
Location
US010
Start Date
2015-03
Trial ID
NCT02174094
This clinical study is conducted to assess the efficacy of cadazolid compar...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-12
Trial ID
NCT01983683
Treatments Being Tested
To evaluate the pharmacokinetic (PK) characteristics after multiple oral ad...
Status
Completed
Location
Xuhui Center Hospital
Start Date
2014-04
Trial ID
NCT02174523
Treatments Being Tested
The purpose of this study is to compare the safety and immunogenicity of a ...
Status
Completed
Location
University of Kentucky
Start Date
2012-04
Trial ID
NCT01585181
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Inves...
Status
Recruiting
Location
Laboratory for Muscle Diseases and Neuropathies
Start Date
2025-02-13
Trial ID
NCT06523400
Treatments Being Tested